MedTrace Logo

Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer

NCT02877056 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2019-05-29

No results posted yet for this study

Summary

The goal of this laboratory research is to look for genes that can predict which patients will achieve a complete disappearance of their colorectal cancer after treatment like chemotherapy, radiation, or other therapy.

This is an investigational study. Up to 350 patients will take part in this study. All will be enrolled at MD Anderson.

Conditions

Interventions

PROCEDURE

Endoscopy

Tissue samples taken from tumor and normal colorectal tissue during standard endoscopy before therapy.

Sponsors & Collaborators

  • Research Foundation of the American Society of Colon and Rectal Surgeons

    collaborator OTHER

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Yi-Qian N. You, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2022-08-31
Completion
2023-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02877056 on ClinicalTrials.gov